ESMO 2019: mCRC drug meets endpoints in Pfizer study - 0 views
-
ramchintamaneni on 22 Oct 19Pfizer has reported positive data from the interim analysis of the Phase III BEACON CRC clinical study being conducted to assess Braftovi.
Last year, I underwent a sleep apnea test and found out that I am really suffering from sleep apnea. As my doctor recommended, I started to use CPAP (Continuous Positive Airway Pressure) but it was...